ACCENDRA HEALTH INC/VA/ ACH
NYSE Price as of Nov 13, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Sep 30, 2026
Market cap
$10.00M
P/E (GAAP, TTM)
—
P/E (operating)
0.46
Dividend yield
0.0%
Revenue growth YoY
-13.7%
EPS growth YoY
87.1%
ROIC
—
Piotroski F-score
2
Three ways to read the P/E
P/E (GAAP, TTM)
—
Net income of the last 4 quarters. Includes investment gains and one-time items.
P/E (GAAP, annual)
—
Net income of the latest fiscal year. Includes investment gains and one-time items.
P/E (operating)
0.46
After-tax operating income only: the core business.
P/E (excl. gains)
—
Net income after removing identified investment and asset-sale gains.
How it has changed
Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.
| Metric | 2026Q3 | 2026Q2 | Change QoQ | 2025Q3 | Change YoY |
|---|---|---|---|---|---|
| Revenue growth YoY (qtr) | -10.1% | -6.8% | -3.2 pts | 3.3% | -13.3 pts |
| EPS growth YoY (qtr) | 89.7% | 75.0% | +14.7 pts | -2,590.5% | +2,680.2 pts |
| Revenue growth (TTM) | 247.0% | 266.4% | -19.3 pts | 3.1% | +243.9 pts |
| EPS growth (TTM) | 74.9% | -195.6% | +270.5 pts | -2,743.6% | +2,818.5 pts |
| P/E (GAAP, TTM) | — | — | — | — | — |
| P/E (operating) | 2.02 | 12.12 | -10.10 | — | — |
| P/E (excl. gains) | — | — | — | — | — |
| P/B | — | — | — | — | — |
| ROIC | — | — | — | -28.6% | — |
| Net margin | -39.8% | -39.8% | 0.0 pts | -13.5% | -26.3 pts |
| Dividend yield | 0.0% | 0.0% | 0.0 pts | — | — |
| EPS (TTM) | -3.93 | -14.07 | +72.1% | -15.64 | +74.9% |
| Price | $0.5700 | $3.42 | -83.3% | — | — |
History by quarter-end
Reported quarters
| Quarter ended | Revenue | QoQ | YoY | EPS | QoQ | YoY | Net margin |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $601.78M | -1.9% | -13.7% | -0.25 | 78.4% | 87.1% | -3.3% |
| Jun 30, 2026 | $613.23M | -2.3% | -10.1% | -1.16 | -1,350.0% | 89.7% | -14.5% |
| Mar 31, 2026 | $627.78M | -11.5% | -6.8% | -0.08 | 89.3% | 75.0% | -1.0% |
| Dec 31, 2025 * | $708.97M | 1.7% | 155.4% | -0.75 | 61.3% | 80.6% | -7.9% |
| Sep 30, 2025 | $697.26M | 2.3% | 1.5% | -1.94 | 82.8% | -1,112.5% | -21.6% |
| Jun 30, 2025 | $681.92M | 1.2% | 3.3% | -11.30 | -3,431.3% | -2,590.5% | -127.4% |
| Mar 31, 2025 | $673.88M | 152.7% | -74.2% | -0.32 | 91.7% | -10.3% | -3.7% |
| Dec 31, 2024 * | -$1.28B | -286.3% | 75.0% | -3.86 | -2,312.5% | -1,708.3% | 23.1% |
| Sep 30, 2024 | $686.85M | 4.0% | -73.5% | -0.16 | 61.9% | -100.0% | -1.9% |
| Jun 30, 2024 | $660.40M | -74.7% | -74.2% | -0.42 | -44.8% | -13.5% | -4.8% |
| Mar 31, 2024 | $2.61B | 151.0% | 3.6% | -0.29 | -220.8% | 9.4% | -0.8% |
| Dec 31, 2023 * | -$5.13B | -297.8% | -300.9% | 0.24 | 400.0% | 131.6% | -0.3% |
* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.
All figures
Price & size
| Fiscal year end | Dec 31, 2025 | End date of the latest annual (10-K) report used. |
|---|---|---|
| Price date | Nov 13, 2026 | Date of the latest closing price used. |
| Price | $0.1300 | Latest closing price. |
| Market cap | $10.00M | Price × shares outstanding. |
| Enterprise value | -$21.99M | Market cap + debt − cash: the price of the whole business. |
| Shares | 76.92M | Shares outstanding used for market cap. |
Valuation
| P/E (GAAP, annual) | — | Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative. |
|---|---|---|
| P/E (GAAP, TTM) | — | Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items. |
| P/E (operating) | 0.46 | Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items. |
| P/E (operating, TTM) | 3.00 | Market cap ÷ after-tax operating income of the last four quarters. |
| P/E (excl. gains) | — | Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified. |
| PEG | — | P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap. |
| PEG (TTM) | — | TTM P/E ÷ TTM EPS growth rate (in %). |
| Earnings yield | -11,006.2% | Net income ÷ market cap. The inverse of the P/E. |
| Earnings yield (TTM) | -1,723.1% | TTM EPS ÷ price. |
| P/B | — | Market cap ÷ shareholders' equity. Blank when equity is negative. |
| P/S | 0.00 | Market cap ÷ revenue of the latest fiscal year. |
| P/S (TTM) | 0.00 | Market cap ÷ revenue of the last four quarters. |
| P/FCF | — | Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative. |
| EV/EBITDA | -0.09 | Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels. |
| EV/EBIT | -0.80 | Enterprise value ÷ operating income. |
| EV/Sales | -0.01 | Enterprise value ÷ revenue. |
| Book value / share | — | Shareholders' equity ÷ shares. |
| FCF yield | — | Free cash flow ÷ market cap. |
Operating vs. one-time earnings
| Operating EPS | 0.28 | After-tax operating income per share (latest fiscal year). |
|---|---|---|
| Investment gains | — | Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified. |
| Asset-sale gains | $27.27M | One-time gains or losses from selling property, assets or businesses. Blank = none identified. |
| Non-operating income | -$129.41M | Pre-tax income minus operating income: interest, investment results and one-time items combined. |
| Gains as % of net income | 2.0% | Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains. |
Latest quarter & trailing 12 months
| Latest quarter | Sep 30, 2026 | End date of the most recent reported quarter. |
|---|---|---|
| Revenue (qtr) | $601.78M | Revenue of the latest reported quarter. |
| Net income (qtr) | -$19.70M | Net income of the latest reported quarter. |
| EPS (qtr) | -0.25 | Diluted EPS of the latest reported quarter. |
| Revenue growth YoY (qtr) | -13.7% | Latest quarter revenue vs the same quarter a year earlier. |
| Revenue growth QoQ (qtr) | -1.9% | Latest quarter revenue vs the previous quarter. |
| EPS growth YoY (qtr) | 87.1% | Latest quarter EPS vs the same quarter a year earlier. |
| EPS growth QoQ (qtr) | 78.4% | Latest quarter EPS vs the previous quarter. |
| Net income growth YoY (qtr) | 86.9% | Latest quarter net income vs the same quarter a year earlier. |
| Net income growth QoQ (qtr) | 77.9% | Latest quarter net income vs the previous quarter. |
| Gross margin (qtr) | — | Gross profit ÷ revenue in the latest quarter. |
| Operating margin (qtr) | 0.2% | Operating income ÷ revenue in the latest quarter. |
| Net margin (qtr) | -3.3% | Net income ÷ revenue in the latest quarter. |
| Revenue (TTM) | $2.55B | Revenue of the last four quarters. |
| Net income (TTM) | -$171.56M | Net income of the last four quarters. |
| EPS (TTM) | -2.24 | Sum of the last four quarters of diluted EPS. |
| Revenue growth (TTM) | 230.0% | Last four quarters of revenue vs the four quarters before. |
| EPS growth (TTM) | 87.1% | Last four quarters of EPS vs the four quarters before. |
| Net income growth (TTM) | 87.2% | Last four quarters of net income vs the four quarters before. |
Dividends & shareholder returns
| Dividend yield | 0.0% | Dividends paid per share over the last 12 months ÷ price. |
|---|---|---|
| Dividend / share (TTM) | — | Dividends per share paid over the last 12 months. |
| Payout ratio | — | Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings. |
| FCF payout ratio | — | Dividends ÷ free cash flow. |
| Dividend growth (1y) | — | Dividends per share vs the same 12-month window a year earlier. |
| Dividend CAGR (3y) | — | Annualised dividend growth over 3 years. |
| Dividend CAGR (5y) | — | Annualised dividend growth over 5 years. |
| Payments (12m) | — | Number of dividend payments in the last 12 months. |
| Last ex-dividend date | Jun 22, 2023 | Most recent ex-dividend date. |
| Buyback yield | 101.8% | Share repurchases ÷ market cap. |
| Shareholder yield | 101.8% | Dividend yield + buyback yield. |
Profitability
| Gross margin | 46.7% | Gross profit ÷ revenue (latest fiscal year). |
|---|---|---|
| EBITDA margin | 8.8% | EBITDA ÷ revenue. |
| Operating margin | 1.0% | Operating income ÷ revenue. |
| Net margin | -39.8% | Net income ÷ revenue. |
| FCF margin | — | Free cash flow ÷ revenue. |
| ROE | — | Return on equity: net income ÷ shareholders' equity. Blank when equity is negative. |
| ROA | -44.9% | Return on assets: net income ÷ total assets. |
| ROIC | — | Return on invested capital: after-tax operating income ÷ (equity + debt − cash). |
Growth (annual)
| Revenue growth (annual) | 3.1% | Latest fiscal year revenue vs the year before. |
|---|---|---|
| Net income growth (annual) | -203.5% | Latest fiscal year net income vs the year before. |
| EPS growth (annual) | -202.5% | Latest fiscal year diluted EPS vs the year before. |
| Revenue CAGR (3y) | -34.8% | Annualised revenue growth over 3 fiscal years. |
| EPS CAGR (3y) | — | Annualised EPS growth over 3 fiscal years. |
Financial health
| Current ratio | 0.58 | Current assets ÷ current liabilities. Above 1 means short-term bills are covered. |
|---|---|---|
| Quick ratio | 0.50 | (Current assets − inventory) ÷ current liabilities. |
| Cash ratio | 0.30 | Cash ÷ current liabilities. |
| Debt / equity | — | Total debt ÷ shareholders' equity. Blank when equity is negative. |
| Debt / assets | 0.10 | Total debt ÷ total assets. |
| Debt / EBITDA | 1.03 | Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt. |
| Net debt / EBITDA | -0.13 | (Debt − cash) ÷ EBITDA. Negative means more cash than debt. |
| Interest coverage | 0.26 | Operating income ÷ interest expense. |
Earnings quality
| FCF conversion | — | Free cash flow ÷ net income. Above 100% means profits turn into real cash. |
|---|---|---|
| Accruals ratio | — | (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings. |
| Stock comp % revenue | 0.5% | Share-based compensation ÷ revenue. |
| R&D % revenue | — | Research & development spending ÷ revenue. |
| SG&A % revenue | 38.7% | Selling, general & administrative expense ÷ revenue. |
| Tax rate used | 21.0% | Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown). |
Efficiency
| Asset turnover | 1.13 | Revenue ÷ total assets. |
|---|---|---|
| Days sales outstanding | — | Average days to collect payment from customers. |
| Days inventory | 18 | Average days inventory is held. |
| Days payables | 90 | Average days to pay suppliers. |
Trading & momentum
| 52-week high | $4.69 | Highest price in the last 52 weeks. |
|---|---|---|
| 52-week low | $0.1200 | Lowest price in the last 52 weeks. |
| From 52-week high | -97.2% | How far below the 52-week high the price is (0% = at the high). |
| Above 52-week low | 8.3% | How far above the 52-week low the price is. |
| Avg volume (30d) | 3.91M | Average shares traded per day over the last 30 days. |
| Avg $ volume (30d) | $917.88K | Average dollars traded per day over the last 30 days: a liquidity measure. |
Scores
| Piotroski F-score | 2 | Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail. |
|---|---|---|
| Altman Z-score | 0.35 | Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers. |
Reported figures (latest fiscal year)
| Revenue | $2.76B | Revenue of the latest fiscal year. |
|---|---|---|
| Net income | -$1.10B | Net income of the latest fiscal year. |
| Diluted EPS | -14.31 | Diluted earnings per share of the latest fiscal year. |
| EBITDA | $241.98M | Operating income + depreciation & amortization. |
| Free cash flow | — | Operating cash flow − capital spending. |
| Total debt | $250.00M | Long-term plus current debt. |
| Cash | $281.99M | Cash and equivalents. |
| Equity | -$460.98M | Shareholders' equity. |
| Total assets | $2.45B | Total assets. |